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Introduction
Osteosarcoma (OS) is a common cancer of the musculoskeletal system in teens and is a leading cause of cancer death and disability worldwide [1] . The most involved sites are the distal femur, the proximal humerus, the proximal tibia, and the metaphysis [2] . The age of peak incidence rate ranges from 14 to 26 years old, especially 14 to 19 years old, and this constitutes a separate specific subgroup who suffer osteosarcoma [3] . The clinical manifestations of OS include local persistent pain, palpable lumps, swelling, dysfunction, and pathological fractures [4] . Osteosarcoma has a poor prognosis because of its highly malignant biological characteristics and metastatic tendencies [5, 6] . The five-year relative survival rates (%) for childhood and adolescent OS in the United States from 2007 to 2013 ranged from 69.8% to 69.5% [1] . The current therapeutic methods adopted for OS are surgical resection and clinical chemotherapy, especially neoadjuvant chemotherapy (NAC) [7] [8] [9] . The purpose of osteosarcoma neoadjuvant chemotherapy is to reduce the primary tumour size, eliminate (micro-)metastatic deposits, maximize limb function retention and minimize patient suffering, trauma and treatment-related adverse outcomes [10, 11] . NAC has been proven to be ineffective in approximately half of OS patients [12] . Therefore, reliable early imaging predictors are vital to early evaluation of the OS treatment response of NAC to optimize the therapeutic regimen individually and reduce ineffectively toxic therapy. [12] . There has been growing interest in utilizing functional imaging techniques to predict early therapeutic efficacy. Conventional magnetic resonance imaging (MRI) can be used to evaluate the tumors and metastasis in pretherapeutic patients, but reevaluating after therapy is also challenging [13] . In addition, diagnostic assessment by using conventional MRI may be hampered by difficulties in distinguishing residual tumor from NAC-induced fibrosis, and the edema can potentially lead to being over-evaluated [14] . Diffusionweighted imaging (DWI), which is based on the Brownian motion of water molecules and can reflect the thermal motion of water molecules at the cellular levels [15] , may be helpful in differentiation and thus improve the early prediction of response after NAC [16] . Therapy-induced cellular necrosis gives rise to increasing water diffusivity. The apparent diffusion coefficient (ADC) is currently used to reflect the magnitude of diffusion and can be calculated with a monoexponential function. But along with pure molecular diffusion, microcirculation within capillary networks also contributes to the ADC value [16] . Here, a functional MRI technique, intravoxel incoherent motion (IVIM), was introduced to separate microcapillary perfusion from DWI data with multiple b values in biexponential model and has been widely investigated in the assessment of therapeutic responses before and after chemotherapy in many malignant tumours [17, 18] . Le Bihan et al. [19] proposed the IVIM dual exponential imaging mode with multiple b values to depict perfusion and diffusion effects in tissues [20] . Another advantage of IVIM is that the derived parameters, including the apparent diffusion coefficient (ADC), (slow) diffusion coefficient (D), pseudo-perfusion (fast) diffusion coefficient (D * ), and perfusion fractions (f ), can be calculated without contrast injection [19, 21] . ADC is sensitive to water molecules in the tissues and can reflect tissue diffusion and perfusion [22] ; the D value is generally considered to be the pure diffusion coefficient, reflecting extracellular and extravascular tissue water molecular motion [23, 24] . The and D * values have the advantage of reflecting tumour angiogenesis and correlating with microvessel density (MVD) scores in tumours [24, 25] . Because of the great potential in the tumour evaluation and grading, IVIM is used widely to assess the NAC therapeutic responses in various malignant tumours [26] [27] [28] . To date, few studies have reported application of the IVIM technique in OS and focus on the evaluation of the OS response to NAC. Thus, the aim of this study was to investigate the value of the IVIM in evaluating the OS therapeutic response to NAC and determine whether the IVIM-derived parameters could serve as imaging biomarkers in OS patients with NAC.
Materials and Methods
. . Patients. This study was approved by the institutional review board of our hospital. Written informed consent was obtained from all patients before the study, and the study was performed according to the ethical guidelines of our institutional clinical research committee. To guarantee the accuracy of the results, the OS located in the distal femoral metaphysis were selected. All patients enrolled who received NAC and underwent knee MRI examinations in this study met the following criteria: (1) all patients had completed NAC and surgery; (2) the first MRI was performed before the initiation of NAC; (3) the second MRI was performed after the completion of NAC; and (4) the NAC course was 2 cycles (4 weeks). The NAC regimens consisted of cisplatin (100-120 g/m 2 ) and doxorubicin (60 g/m 2 ). Patients were given folic acid during chemotherapy. The treatment response and physical situation were observed closely and recorded. The patients in this study did not receive radiotherapy.
. . Treatment Response Analysis. Therapeutic response was determined by the final tumor size on MRI 2 cycles after NAC. The responses could be classified clinically into four types based on RECIST: (1) Complete response (CR), no residual tumor tissues on T2WI; (2) partial response (PR), the maximum diameter of the tumor less than 70% of the original size; (3) progressive disease (PD), at least a 20% increase in the sum of longest diameter of the tumor; (4) stable disease, neither sufficient shrinkage to be as PR nor sufficient increase to be as PD. The maximum diameter was recorded before treatment as the reference [29] .
. . MR Imaging. All patients underwent whole-body 3.0 T MR scans (Discovery MR750; GE Healthcare, MI) using a special knee coil. Conventional MRI sequences included axial spin-echo T1-weighted images (T1WI) (TR/TE, 512/12.4 ms), axial, coronal, and sagittal fast spin-echo T2-weighted images (T2WI) with or without fat suppression (2500/71 ms). Axial diffusion weighted imaging (DWI) was performed using single-shot spin-echo echo-planar imaging sequence (3225/69.2 ms) with 256 ×256 matrix, slice thickness: 5 mm, slice gap: 1 mm, field of view (FOV): 150-200, EPI factor of 5, and b-values of 0, 50, 150, 200, 400, 800, 1000 and 1200 s/mm 2 ; the total scan time was 4 min and 24 seconds.
For the dynamic contrast-enhanced MRI (DCE-MRI) sequence, the transverse 3D fast spoiled gradient recalled echo (FSPGR) sequence with fat saturation was scanned after intravenous administration of 0.1 mmol/kg Gd-DTPA (Magnevist, Germany) at 2 ml/s (with a flush of 20 mL saline solution) via a high-pressure injector within 15 seconds.
. . MRI Data and Image Analysis. The conventional sequences (T1WI, T2WI) and DCE are used to be the auxiliary methods to observe and measure the OS, including the signal intensity (SI), size and volume (V) changes before and after NAC. The volume was calculated with the equation V= L×W×W/2 (V: volume; L: length; W: width) [30] . The volume changes of the OS (ΔV) were measured and calculated (Δ V = |V before NAC -V after NAC |).
ADC values were calculated using a monoexponential model with all the values [19] : 
S: the SI with diffusion sensitization; 0 : the SI without diffusion sensitization. Briefly, for IVIM analysis, MATLAB (MathWorks, Natick, MA) was used to analyse the data measured on the diffusion-weighted images. The ADC was measured using a monoexponential model, and IVIM parameters were calculated using 8 b values fitted to a biexponential model (0-1200 s/mm 2 ) proposed by Le Bihan et al. [19] . For the region of interest (ROI), the areas with homogeneous signal intensities were selected; round areas (approximately 50-150 mm 2 ) were drawn manually on the parametric maps with reference to the T2W images by 2 radiologists who had more than 5 years of MRI diagnosis experience. Notably, ROIs drawing should avoid the areas of focal SI changes, susceptibility artifacts, large necrosis and cystic areas and haemorrhage. All the data were measured 3 times to obtain mean values. T2WI and DCE-MR images were used to determine the lesion range on the IVIM parametric maps. All the data and volumes calculated were processed on an ADW 4.4 workstation (GE Healthcare). The changes in the IVIM parameters before NAC and after 2 cycles of NAC (Δ ADC , Δ D , Δ D * and Δ ) were calculated with the same method of Δ V .
. . Statistical Analysis. All the data were expressed as the mean ± standard deviation. The normal distribution of all the data were tested with the Kolmogorov-Smirnov test. For ADC, D, D * and f, the differences before NAC and after 2 cycles of NAC were compared using Student's t-test.
Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic performance of IVIM parameters to predict the response before and after NAC; the areas under the ROC curve (AUC), sensitivity, and specificity were also calculated. Diagnostic accuracy was defined according to AUC values (AUC≥0.9 indicated very good accuracy; 0.9 > AUC ≥ 0.7 indicated reasonable accuracy; 0.7 > AUC≥ 0.5 indicated poor accuracy; 0.5 > AUC indicated no accuracy). The optimal threshold (cutoff) was chosen according to the Youden index.
The relationship between the volume changes of the OS (Δ V ) and the changes in the quantitative parameters (Δ ADC , Δ D , Δ D * and Δ ) were determined using Spearman correlation analysis.
All the analyses were performed using SPSS 19.0 software for Windows (IBM Corporation, Armonk, NY, USA). P<0.05 was considered statistically significant.
The level of the intra-observer agreement was tested by Bland-Altman's variation coefficient using MedCalc (Version 18.2.1, Mariakerke, Belgium). The variation coefficient <10% was defined as acceptable.
Results

. . Patients erapeutic Response and the OS Volume before
and a er NAC. After 2 cycles of NAC, none patients were determined as CR and PD, 16 patients were determined as PR, and 2 patients were determined as stable disease, but the size decreased.
The volume of the OS after NAC decreased to varying degrees. The mean volume of the OS was 61.55±9.3 cm 3 before NAC, and the mean volume of the OS was 40.26±4.1 cm 3 after NAC (P<0.05).
. . MRI Imaging Findings and the Mean Values of ADC, D, D * and f.
The OS was heterogeneous, showing hypointensity on T1WI and hyperintensity on T2WI and DWI.
The intra-observer variation coefficients of the ADC, D, D * and fvalue were low, with an average error of 5% coefficient of variance (less than 10%), indicating a good intra-observer agreement level. After 2 cycles of NAC, some necrotic areas could be observed in the middle of the OS (Figure 1 Table 1 (Figures 3 and 4) . 
Discussion
We investigated the value of IVIM in evaluating the osteosarcoma response to preoperative neoadjuvant chemotherapy in teens. We found that the ADC and D values increased significantly after 2 cycles of NAC, and the D * and values decreased; however, no significant difference was observed in D * before and after NAC. Furthermore, we found that the sensitivity and the specificity of the ADC and D were much higher than the D * and values. Nevertheless, no correlation was found between the volume and the IVIM parameter changes before and after NAC. All data suggested that IVIM could be a potential imaging biomarker of the OS chemotherapeutic response to preoperative NAC.
NAC before surgery and limb salvage treatment is the optimal and standard choice for osteosarcoma patients [31] . To preserve limb function, as well as to minimize the possible local recurrence and improve the quality of life, marginal resection was proposed for OS patients with favourable responses to NAC. In a study, with median follow-up of 5.5 years, the overall 5-year cumulative survival rate was 61.7%, and excellent to good function of the affected limb was reported for 57.7% of OA patients undergoing marginal resection after NAC [32] .
After NAC, functional MRI reflects the internal microenvironment changes in the tumour and predicts the response of the tumour to NAC [33, 34] . IVIM differentiates microvascular perfusion activity (b values<200 s/mm 2 ) from diffusion (b values > 200 s/mm 2 ). Therefore, IVIM was used widely in oncologic imaging and assessments of NAC [26, 27] . In our study, these results are consistent with the theory that cell density and microvessel density (MVD) might be altered greatly after NAC. After NAC, the true molecular diffusion and water molecules motion increased with less restriction due to larger extracellular spaces, yielding higher ADC and D values [26, 35] . The D value was the marker of true molecular diffusion and water molecule diffusion related to the size of the intracellular and extracellular spaces; therefore, the larger the area of stromal tissue in the tumour appears, the higher the ADC and D values are [36] . After the course of NAC, cellular density in highly cellular tumour tissues decreased dramatically, leading to significant alterations in ADC and D values and better responses to NAC [27, 36] . These results were similar to those of previous studies [28, 37] and other tumours [38, 39] . These findings suggest that microcirculation or perfusion effects can differ from true tissue diffusion by multiple b values and the biexponential curve fit analysis with IVIM imaging [19, 37] . The ADC and D values had much higher AUC, sensitivity and specificity, consistent with previous studies [26, 28] . With the aid of IVIM, true molecular diffusion and water molecule motion in the capillary network could be evaluated with one-time imaging acquisition.
We also found that IVIM-derived values decreased and showed significant differences; however, they had lower AUC and sensitivity than the ADC and D values. Theoretically, the more the microvascular structures were destroyed and decreased in good responders to NAC, the greater the reduction in the value was. However, because of many factors, including the wide range of the values among the patients, poor interobserver agreement and T2 contributions of both perfusion and pure molecular diffusion compartments [27, 40] , the values reported were different, and the usefulness was not identified [37] . In the biexponential IVIM model, f is defined as the blood capillary and tumour tissue signal intensity ratio. All relaxation effects could be ignored if the relaxation times of the capillary blood and the tumour were similar. However, the T2 contributions of the tumour and blood capillaries were substantially different, and especially in tumours after NAC, T2 values tended to increase, which could lower the values artificially [40] . Therefore, the f values may be useful in the evaluation of OS response to NAC; however, this should be done with much caution.
The D * value did not show significant changes before and after NAC and was not useful for the evaluation of tumour response. By comparison with ADC and D, D * had its limitation, including less signal attenuation variability, high uncertainty, and poor measurement reproducibility [41, 6 Concepts in Magnetic Resonance Part A 42]. In OS before and after NAC, no significant differences were observed; we speculated that D * data might have large standard deviations that were unstable and dependent on the signal-to-noise ratio levels [15, 41] . In addition, the heterogeneity in tumour and noise variations could also affect the D * values [15] . Our findings are concordant with those of previous studies on cancers [27, 28, 36] , and the results suggested that D * has limited value in the assessment of tumour responses to CRT [41] .
However, although the changes in the V, ADC, D and values before and after NAC showed significant differences, no correlation was found between Δ V and Δ ADC , Δ D and Δ . We believe this may be related to cellular degeneration, tissue necrosis, and individual differences [15, 22] . Further studies should be performed to obtain more accurate data.
Some limitations should be mentioned. First, the study size was relatively small, possibly having some effect on the results. Second, two NAC cycles for the observation are relative short; the majority OS patients were in the state of PR, so it lacks the investigation of the Long-term therapeutic efficacy. Third, we focused on the early therapeutic response, lacking long-term survival outcomes analysis. Fourth, no comparison was performed between the IVIMderived parameters and the dynamic contrast enhanced parameters, possibly reducing the convincing power of our data. We will continue to improve the study design regarding the above limitations in future studies.
In summary, D and ADC values are useful for evaluating and monitoring the efficacy of NAC in OS patients. Therefore, IVIM-MRI can be an effective potential imaging biomarker in early prediction of the therapeutic response to NAC in OS patients.
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